Ganciclovir/Valganciclovir Prophylaxis Decreases Cytomegalovirus-Related Events and Bronchiolitis Obliterans Syndrome after Lung Transplantation | Zendy

Corinne Chmiel | Zendy; Rudolf Speich | Zendy; Markus J. Hofer | Zendy; Detlef Michel | Zendy; Thomas Mertens | Zendy; Walter Weder | Zendy; A. Boehler | Zendy

Open Access

Ganciclovir/Valganciclovir Prophylaxis Decreases Cytomegalovirus-Related Events and Bronchiolitis Obliterans Syndrome after Lung Transplantation

Author(s) -

Corinne Chmiel,

Rudolf Speich,

Markus J. Hofer,

Detlef Michel,

Thomas Mertens,

Walter Weder,

A. Boehler

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/528689

Subject(s) - medicine , valganciclovir , ganciclovir , bronchiolitis obliterans , regimen , gastroenterology , cytomegalovirus , incidence (geometry) , transplantation , lung transplantation , immunology , human cytomegalovirus , virus , herpesviridae , viral disease , physics , optics

Until recently, cytomegalovirus (CMV) infection represented a major threat to lung transplant recipients. Preliminary studies have shown that antiviral prophylaxis might improve the outcome for these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research